万维提示：
1、投稿方式：在线投稿。
2、期刊网址：https://www.springer.com/journal/10147/
3、投稿网址：https://www.editorialmanager.com/ijco
4、官网邮箱：相关咨询邮箱如下。
5、期刊刊期：月刊，一年出版12期。
2021年8月2日星期一
期刊相关咨询邮箱【官网信息】
Contact the journal
Submission-related enquiries
Queries about submission issues, peer review process, or the status of your manuscript should be sent to Magesh Nagarajan (Magesh.Nagarajan@springernature.com).
Production-related enquiries
Queries about accepted manuscripts in production or post-publication corrections should be sent to Aravindhan Jeyaraj (Aravindhan.Jeyaraj@springer.com).
Rights and Permissions enquiries
For permission requests to reuse or reprint content, please follow the link ‘Rights and permissions’ on the relevant article page. For other queries, contact journalpermissions@springernature.com.
Publication-related enquiries
Queries related to journal publishing should be sent to Yoko Arai (yoko.arai@springer.com).
投稿须知【官网信息】
International Journal of Clinical Oncology
Submission guidelines
Instructions for authors
Manuscript submission
Legal requirements:
Submission of a manuscript implies: that the work described has not been published before; that it is not under consideration for publication anywhere else; that its publication has been approved by all co-authors, if any, as well as by the responsible authorities – tacitly or explicitly – at the institute where the work has been carried out. The publisher will not be held legally responsible should there be any claims for compensation.
Prerequisites for publication:
A copy of the certification form included in each issue must be submitted to the journal’s editorial office at the same time you submit your manuscripts via Editorial Manager.
Certification form (Download pdf, 284 kB)
Permissions:
Authors wishing to include figures, tables, or text passages that have already been published elsewhere are required to obtain permission from the copyright owner(s) for both the print and online format and to include evidence that such permission has been granted when submitting their papers. Any material received without such evidence will be assumed to originate from the authors.
Online submission:
Authors should submit their manuscripts to the International Journal of Clinical Oncology online. No manuscripts will be accepted by mail or fax. Please log in directly at: http://www.editorialmanager.com/ijco and upload your manuscript following the instructions given.
Potential conflict of interest
Authors must indicate whether or not they have a financial relationship with the organization that sponsored the research. They should also state that they have full control of all primary data and that they agree to allow the journal to review their data if requested.
Therefore the manuscript must be accompanied by the "Conflict of Interest Disclosure Statement”. This form at the download below.
The corresponding author also should include a summary statement in the text of the manuscript in a separate section before the reference list, that reflects what is recorded in the "Conflict of Interest Disclosure Statement" forms.
IMPORTANT:
Upon receipt of the certification form and COI form, manuscripts are officially recognized as submissions
Conflict of Interest Disclosure Statement (Download pdf, 284 kB)
Manuscript preparation
Types of articles:
Articles may be in the form of original articles, letters to the editor, review articles, and editorials.
Original articles should not exceed 3,000 words, not including the abstract, references, tables, and figure captions. The text should be arranged in accordance with the format described below in “Text”. Acceptance of an original article is based primarily on the originality of the work and its potential clinical influence. For reports of randomized controlled trials, authors should refer to the CONSORT statement of guidelines (http://www.consort-statement.org). For studies of the diagnostic accuracy of tests, authors are encouraged to refer to the STARD statement (http://www.stard-statement.org/).
Letters to the editor may offer criticism of published material. They must be objective, constructive, and educational, and should not exceed 500 words, not including references, tables, and figure captions.
Review articles provide an overview of the state of the art in an area or an update in an area of current interest in clinical oncology. They should be approximately 3,000 words not including the abstract, tables, figure captions, and have a maximum of 75 references.
Editorials may be published as viewpoints of the editor(s) of the journal on current, relevant topics.
Manuscript form:
The abstract, text, references, tables, and figure captions must be typed double-space with wide margins. Incomplete or improperly prepared manuscripts will be returned to the authors without review. A separate cover page should be provided. The abstract, text, acknowledgments, references, tables, captions, and figures should begin on separate sheets and follow in that order. Standard abbreviations and units should be used. Abbreviations should be defined at first appearance, and their use in the title and abstract should be avoided. Generic names of drugs and chemicals should be used.
All manuscripts must be written in English. Authors who are not fluent in English must seek the assistance of a colleague who is a native English speaker and is familiar with the field of the work.
Cover page:
The cover page should contain the title, the full names of the authors, and the street address of the authors’ academic affiliations. Please supply a fax number, telephone number, and e-mail address for the proofs.
Abstract:
The abstract should be comprehensible without reference to the text, and the use of abbreviations should be avoided whenever possible. The abstract should not exceed 250 words and should be arranged under the following subheadings for original articles: (1) Background (the problem being addressed and the purpose of the study); (2) Methods (study design/methods and materials); (3) Results (research findings), and (4) Conclusion(s) (summary of the main findings obtained and the conclusions drawn).
Key words:
3-6 key words should be listed below the abstract.
Text:
The text should be arranged as follows: (1) Introduction; (2) Patients and methods, or Materials and methods; (3) Results; (4) Discussion; (5) Acknowledgment(s). The sections should describe: (1) the problem being addressed and the purpose of the study with reference to previous findings; (2) materials and methods used in the study in concise yet sufficient detail to allow the study to be replicated; (3) main findings obtained; (4) conclusions drawn from the findings and implications for further research and clinical application, with a review of relevant published literature and other evidence.
Text formatting:
Manuscripts should be submitted in Word.
• Use a normal, plain font (e.g., 10-point Times Roman) for text.
• Use italics for emphasis.
• Use the automatic page numbering function to number the pages.
• Do not use field functions.
• Use tab stops or other commands for indents, not the space bar.
• Use the table function, not spreadsheets, to make tables.
Footnotes:
Footnotes can be used to give additional information, which may include the citation of a reference included in the reference list. They should not consist solely of a reference citation, and they should never include the bibliographic details of a reference. They should also not contain any figures or tables. Footnotes to the text are numbered consecutively; those to tables should be indicated by superscript lower-case letters (or asterisks for significance values and other statistical data). Footnotes to the title or the authors of the article are not given reference symbols. Always use footnotes instead of endnotes.
References
Citation:
Reference citations in the text should be identified by numbers in square brackets. Some examples:
1. Negotiation research spans many disciplines [3].
2. This result was later contradicted by Becker and Seligman [5].
3. This effect has been widely studied [1-3, 7].
Reference list
The list of references should only include works that are cited in the text and that have been published or accepted for publication. Personal communications and unpublished works should only be mentioned in the text. Do not use footnotes or endnotes as a substitute for a reference list. The entries in the list should be numbered consecutively. Give the names of the first three authors only, followed by “et al” if there are other coauthors.
Journal article
1. Smith J, Jones M Jr, Houghton L, et al (1999) Future of health insurance. N Engl J Med 965:325–329
2. Inoue T, Sue K, Nakano K, et al. (1991) A case report of long survival in a 17-year-old girl with gastric carcinoma treated by immunochemo-endocrine therapy (in Japanese). Shinyaku to Rinsho (New Med) 40:117–121
Article by DOI
3. Slifka MK, Whitton JL (2000) Clinical implications of dysregulated cytokine production. J Mol Med (in press). doi: 10.1007/s001090000086
Book
4. South J, Blass B (2001) The future of modern genomics. Blackwell, London
Book chapter
5. Brown B, Aaron M (2001) The politics of nature. In: Smith J (ed) The rise of modern genomics, 3rd edn. Wiley, New York, pp230-257
Online document
6. Doe J (1999) Title of subordinate document. In: The dictionary of substances and their effects. Royal Society of Chemistry. Available via DIALOG. http://www.rsc.org/dose/title of subordinate document. Accessed Jan 1999
Dissertation
7. Trent JW (1975) Experimental acute renal failure. Dissertation, University of California
Always use the standard abbreviation of a journal’s name according to the ISSN List of Title Word Abbreviations, see http://www.issn.org/2-22661-LTWA-online.php
EndNote style file (Download zip, 19 kB)
Tables
• All tables are to be numbered using Arabic numerals.
• Tables should always be cited in text in consecutive numerical order.
• For each table, please supply a table caption (title) explaining the components of the table.
• Identify any previously published material by giving the original source in the form of a reference at the end of the table caption.
• Footnotes to tables should be indicated by superscript lower-case letters (or asterisks for significance values and other statistical data) and included beneath the table body.
……
更多详情：
https://www.springer.com/journal/10147/submission-guidelines
